1. Home
  2. CHA vs BRKR Comparison

CHA vs BRKR Comparison

Compare CHA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHA
  • BRKR
  • Stock Information
  • Founded
  • CHA 2017
  • BRKR 1960
  • Country
  • CHA China
  • BRKR United States
  • Employees
  • CHA N/A
  • BRKR N/A
  • Industry
  • CHA
  • BRKR Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CHA
  • BRKR Industrials
  • Exchange
  • CHA NYSE
  • BRKR Nasdaq
  • Market Cap
  • CHA 6.6B
  • BRKR 5.8B
  • IPO Year
  • CHA 2025
  • BRKR 2000
  • Fundamental
  • Price
  • CHA $32.00
  • BRKR $37.52
  • Analyst Decision
  • CHA
  • BRKR Buy
  • Analyst Count
  • CHA 0
  • BRKR 12
  • Target Price
  • CHA N/A
  • BRKR $58.50
  • AVG Volume (30 Days)
  • CHA 2.9M
  • BRKR 2.5M
  • Earning Date
  • CHA 01-01-0001
  • BRKR 05-07-2025
  • Dividend Yield
  • CHA N/A
  • BRKR 0.53%
  • EPS Growth
  • CHA 186.29
  • BRKR N/A
  • EPS
  • CHA 1.95
  • BRKR 0.52
  • Revenue
  • CHA $1,699,604,333.00
  • BRKR $3,446,100,000.00
  • Revenue This Year
  • CHA N/A
  • BRKR $5.57
  • Revenue Next Year
  • CHA N/A
  • BRKR $5.63
  • P/E Ratio
  • CHA $16.64
  • BRKR $72.35
  • Revenue Growth
  • CHA 167.35
  • BRKR 14.84
  • 52 Week Low
  • CHA $29.00
  • BRKR $34.10
  • 52 Week High
  • CHA $41.80
  • BRKR $84.90
  • Technical
  • Relative Strength Index (RSI)
  • CHA N/A
  • BRKR 41.10
  • Support Level
  • CHA N/A
  • BRKR $38.18
  • Resistance Level
  • CHA N/A
  • BRKR $43.09
  • Average True Range (ATR)
  • CHA 0.00
  • BRKR 1.81
  • MACD
  • CHA 0.00
  • BRKR 0.30
  • Stochastic Oscillator
  • CHA 0.00
  • BRKR 21.10

About CHA CHAGEE HOLDINGS LTD SPON ADS EACH R SPON ADS EACH REP 1 CL A

Chagee Holdings Ltd is a premium tea drinks brand. It is engaged in the sales of freshly-made tea drinks, related raw materials, packaging, teahouse equipment and other supplies in China.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: